EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Exploring Asthma as a Protective Factor in COVID-19 Outcomes

Anthony E Quinn iD, Lei Zhao, Scott D Bell iD, Muhammad H Huq, Yujiang Fang

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26041678 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Anthony E Quinn und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Immunology & Pathology, College of Osteopathic Medicine, Des Moines University, West Des Moines, IA 50266, USA. Hauptthemen laut MEDLINE: Asthma, COVID-19. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Des Moines University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Asthma has long been associated with increased susceptibility to viral respiratory infections, leading to significant exacerbations and poorer clinical outcomes. Contrarily and interestingly, emerging data and research surrounding the COVID-19 pandemic have shown that patients with asthma infected with SARS-CoV-2 experienced decreased severity of disease, lower hospitalization rates, as well as decreased morbidity and mortality. Research has shown that eosinophils could enhance immune defense against viral infections, while inhaled corticosteroids can assist in controlling systematic inflammation. Moreover, reduced ACE-2 expression in individuals with asthma may restrict viral entry, and the Th2 immune response may offset the Th1 response typically observed in severe COVID-19 patients. These factors may help explain the favorable outcomes seen in asthmatic patients during the COVID-19 pandemic. This review highlights potential protective mechanisms seen in asthmatic patients, including eosinophilia, the use of inhaled corticosteroids, reduced ACE-2 expression, and a dominate Th2 immune response. Such a study will be helpful to better manage patients with asthma who have contracted COVID-19.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AsthmaCOVID-19HumansAngiotensin-Converting Enzyme 2SARS-CoV-2Adrenal Cortex HormonesTh2 CellsEosinophilsAdministration, Inhalation

Stichwörter der Autor:innen

COVID-19allergyasthma

Substanzen

Angiotensin-Converting Enzyme 2Adrenal Cortex HormonesACE2 protein, human

Autor:innen und Institutionen

  • Department of Microbiology, Immunology & Pathology, College of Osteopathic Medicine, Des Moines University, West Des Moines, IA 50266, USA.
  • The Department of Respiratory Medicine, the 2nd People's Hospital of Hefei and Hefei Hospital Affiliated to Anhui Medical University, Hefei 230002, China.
  • Department of Surgery, University of Missouri School of Medicine, Columbia, MO 65212, USA.
  • Ellis Fischel Cancer Center, University of Missouri School of Medicine, Columbia, MO 65212, USA.

ORCID-Profile: Anthony E Quinn, Scott D Bell

Förderung

  • Des Moines University

Zitieren

APA

Quinn, A. E., Zhao, L., Bell, S. D., Huq, M. H., & Fang, Y. (2025). Exploring Asthma as a Protective Factor in COVID-19 Outcomes. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26041678

Vancouver

Quinn AE, Zhao L, Bell SD, Huq MH, Fang Y. Exploring Asthma as a Protective Factor in COVID-19 Outcomes. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26041678

BibTeX
@article{Quinn2025,
  author = {Quinn, Anthony E and Zhao, Lei and Bell, Scott D and Huq, Muhammad H and Fang, Yujiang},
  title = {Exploring Asthma as a Protective Factor in COVID-19 Outcomes},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26041678}
}
Kostenlos starten →